Dermira (NASDAQ: DERM) reported Q1 EPS of ($0.53), $0.31 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $13 million versus the consensus estimate of $14.25 million.

For earnings history and earnings-related data on Dermira (DERM) click here.